Research & Development



  李敢的黑臉看不出半點不好意思的模樣,倒是趙破奴欽佩的看著霍去病道︰“將軍,還是你心細如發。”   三千多人一起下了一丈寬的小河沐浴,這條小河很快就變成了黑色。2013福利彩票开奖视频   衛青打量了一下那顆干枯的骷髏道︰“是匈奴人!”23日福利彩票   劉徹松了一口氣,對衛青道︰“我們回宮吧,此次北狩,朕非常的滿意!”   直到此刻,眾人才有一種死里逃生的感覺。2014春节彩票休市   “你看起來非常的興奮啊!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo